Improvement in hemolysis and pulmonary arterial systolic pressure in adult patients with sickle cell disease during treatment with hydroxyurea.
Olnes
Matthew
M
Chi
Amy
A
Haney
Carissa
C
May
Rose
R
Minniti
Caterina
C
Taylor
James
J
Kato
Gregory J
GJ
D000328:Adult; D000755:Anemia, Sickle Cell / Q000097:blood / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000401:mortality / Q000503:physiopathology; D000986:Antisickling Agents / Q000008:administration & dosage*; D001119:Arginase / Q000097:blood; D001794:Blood Pressure / Q000187:drug effects*; D018572:Disease-Free Survival; D004452:Echocardiography / Q000379:methods; D005260:Female; D005319:Fetal Hemoglobin / Q000032:analysis; D006461:Hemolysis / Q000187:drug effects*; D006801:Humans; D006918:Hydroxyurea / Q000008:administration & dosage*; D008297:Male; D011651:Pulmonary Artery / Q000503:physiopathology*; D015996:Survival Rate; D014652:Vascular Diseases / Q000097:blood / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000401:mortality / Q000503:physiopathology
D000986:Antisickling Agents; D005319:Fetal Hemoglobin; D001119:Arginase; D006918:Hydroxyurea